CELCUITY INC. Notes Payable, Fair Value Disclosure
CELCUITY INC. (CELC) had Notes Payable, Fair Value Disclosure of $167.80 million as of 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Notes
us-gaap:NotesPayableFairValueDisclosure · last filed 2026-08-13
- 2026-03-31: Notes Payable, Fair Value Disclosure $167.80M.
- 2025-12-31: Notes Payable, Fair Value Disclosure $160.20M.
| Period end | Notes Payable, Fair Value Disclosure |
|---|---|
| 2026-03-31 | $167.80M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $160.20M 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |